12075733

Source:http://linkedlifedata.com/resource/pubmed/id/12075733

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0003392, umls-concept:C0035820, umls-concept:C0205210, umls-concept:C0732165
pubmed:issue	5
pubmed:dateCreated	2002-6-21
pubmed:abstractText	Somatostatin (SST) analogues represent a novel approach for the treatment of certain cancers. The objective of this article is to summarise the current knowledge on SST analogues in the treatment of cancer patients.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9007735
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Octreotide, http://linkedlifedata.com/resource/pubmed/chemical/Peptides, Cyclic, http://linkedlifedata.com/resource/pubmed/chemical/Somatostatin, http://linkedlifedata.com/resource/pubmed/chemical/lanreotide
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	0923-7534
pubmed:author	pubmed-author:HejnaMM, pubmed-author:RadererMM, pubmed-author:SchmidingerMM
pubmed:issnType	Print
pubmed:volume	13
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	653-68
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:12075733-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:12075733-Female, pubmed-meshheading:12075733-Humans, pubmed-meshheading:12075733-Male, pubmed-meshheading:12075733-Neoplasms, pubmed-meshheading:12075733-Octreotide, pubmed-meshheading:12075733-Peptides, Cyclic, pubmed-meshheading:12075733-Randomized Controlled Trials as Topic, pubmed-meshheading:12075733-Sensitivity and Specificity, pubmed-meshheading:12075733-Somatostatin, pubmed-meshheading:12075733-Survival Analysis, pubmed-meshheading:12075733-Treatment Outcome
pubmed:year	2002
pubmed:articleTitle	The clinical role of somatostatin analogues as antineoplastic agents: much ado about nothing?
pubmed:affiliation	Department of Internal Medicine I, University Hospital of Vienna, Austria. michael.hejna@akh-wien.ac.at
pubmed:publicationType	Journal Article, Review